Bristol-Myers Squibb 4Q Revenues: $5.2 billion (+4%) 4Q Earnings: $1.2 billion (loss of $89 million in 4Q08) FY Revenues: $20.6 billion (+13%) FY Earnings: $5.2 billion (+142%) Comments: Pharmaceutical sales were $4.5 billion in the quarter (+4%). U.S. pharmaceutical sales were up 13% to $2.8 billion, while international sales were down 9% to $1.7 billion, primarily due to an 8% unfavorable foreign exchange impact. Plavix sales were $1.5 billion (+7%). Pravachol sales were down 7...